At Reuters Pharma USA in March, ZS Associates' Maria Whitman sat down with pharmaphorum to discuss why it's time to reinvent pharma's marketing strategy
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS